Evaluation of the Efficacy and Safety of Peramivir in Subjects With Uncomplicated Acute Influenza.

NCT00419263 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

344

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

DRUG: Peramivir 150 mg
DRUG: Peramivir 300 mg
DRUG: Placebo

Sponsor

BioCryst Pharmaceuticals